Very Excited to announce something that so many EQUINE VETS and HORSE OWNERS have been waiting for…
The first controlled, double-blinded study on the Equine Tendon using Regenerative Laser (RLT Technology): The Effect of High Intensity Laser Therapy on Healing of Surgically Induced Core Lesions of the Superficial Flexor Tendon.
4 plus years ago, Rick Mitchell, Fairfield Equine, DVM, MRCVS, Dip. ACVSMR, Cert. ISELP approached me with the challenge of conducting a much needed study. After launching this technology into the equine market, and now since ~30,000 horses have been treated with promising clinical outcomes, Sound (formerly Sound-Eklin) made the decision to commission some of the most prominent and respected names in the industry to evaluate the potential in a very controlled, clinically meaningful environment.
This formal evaluation was performed by Michael Schramme, DrMedVet CertEO PhD HDR using his widely accepted surgical model on horses in Lyon, France. The horses have been treated, evaluated, and euthanized, and now the data analysis is well underway. Roy Pool, DVM, PhD is assessing the histopathology on the superficial digital flexor tendon samples, and Norm Rantanen, DVM, MS, DACVR is reviewing the ultrasound and MRI images . Each of the participants is individually blinded and their agreement on the clinical outcomes are being put through the most rigorous statistical analysis.
Preliminary data indicates, among other things, a statistically significant reduction in lesion size, as measured by ultrasound, in the laser group vs the control. The rest of the details will be announced very soon.
To learn more about this technology, please visit www.smartrlt.com
SOUND® is the global veterinary imaging leader and most trusted source for Digital X-ray, Ultrasound systems, Regenerative and Therapeutic lasers, Education, PACS, Advanced Imaging Tools, and Imaging Support.
Special thanks to Michael Schramme, Norm Rantanen, Roy Pool, Roger Smith, Mark Martinelli, Jim Morehead, Rick Mitchell, Bryan Stephens, and Tom Jacobi.